Bhupesh Nadkarni
HIMSS 2026 felt like a market applying pressure on execution.
And it was visible across the event floor, in keynote sessions, and in the conversations healthcare leaders were willing to spend time on. The industry has moved into a more demanding phase of digital adoption. AI is now expected to work inside live environments. Platforms are expected to support measurable outcomes. Governance is expected to be part of the product. Usability is expected from the start. Buyers are asking sharper questions because the stakes are higher and the tolerance for vague value stories is lower.
This shift matters.
Healthcare has spent the last few years exploring the possibilities of AI, automation, cloud modernization, patient engagement, connected devices, and data interoperability. HIMSS 2026 showed what comes next. The market wants technologies that can carry weight inside real workflows. It wants systems that can reduce friction, support decisions, recover time, strengthen control, and hold up in regulated operating environments.
That is where the conversation has become more useful.
At HIMSS 2026, scale and seriousness came together. Around 24,000 attendees from 75 countries gathered in Las Vegas, and nearly one-third of them were C-suite leaders. That level of executive presence changes the tone of an event. The interest is still there. The curiosity is still there. The main difference is that buyers now want a clearer answer to one question: how does this move the organization forward in a way that is measurable, governable, and durable?
Healthcare Has Entered an Accountability Era
The strongest signal from HIMSS 2026 was not excitement. It was accountability.
Healthcare organizations are under pressure from every direction. Costs remain high. Staffing remains tight. Administrative burden continues to drain time and focus. Data environments are still uneven. Patient expectations keep rising. Security concerns are growing. In such settings, technology needs to do more than impress. It needs to perform. This expectation shaped the way major announcements landed at the event.
The examples that drew attention were tied to workflow and outcome. Epic pointed to gains in prior authorization efficiency. Oracle highlighted a lower documentation burden. Abridge surfaced workload and satisfaction improvements. Amazon Health AI shared a reduction in call abandonment. These stories landed because they connected technology to operational value in terms healthcare organizations already understand.
That is where the market is now. Buyers are looking for practical movement across clinical, financial, and operational systems. They want technologies that fit the structure of healthcare work and make that work easier to execute with consistency.
It's a healthy shift for the industry. It raises the standard for builders and creates stronger conditions for adoption. Healthcare benefits when the market rewards systems that can prove relevance under pressure.
AI Will Earn Its Place Inside Workflows
Agentic AI was the loudest theme at HIMSS 2026, though the more important point is where that conversation is heading.
The market is moving toward AI that can take part in the workflow itself. Epic’s Agent Factory, Microsoft’s expansion of Dragon Copilot, and the broader push from Google Cloud, Salesforce, Oracle, and Amazon all pointed in the same direction. AI is moving closer to action, to decision support, and of course, operational participation.
This movement not only brings real opportunity but also a stricter set of requirements in healthcare.
A healthcare workflow is a chain of dependencies. It involves timing, documentation, compliance, handoffs, escalation points, patient communication, and financial consequences. Intelligence in that environment needs to behave with discipline. It needs to surface the right information at the right time. It needs to support action without creating ambiguity. Most importantly, it needs to help teams move through complexity with greater speed and clarity.
This is why the next phase of healthcare AI will be won inside workflows.
Prior authorization, denial management, clinical risk review, intake orchestration, connected device operations, and remote monitoring are all strong examples. These are environments where work slows down because information is incomplete, coordination is fragmented, or teams are forced to repeat the same cognitive effort across cases. Well-designed intelligence can create meaningful lift here because the friction is already visible and the operational need is already established.
For Coditas, this is one of the clearest paths forward. Our focus areas sit inside the kinds of healthcare workflows where intelligence has a real chance to prove value. Revenue cycle teams need stronger orchestration and decision support. Connected care environments need continuity and visibility. Clinical intelligence needs to produce outputs that teams can understand and act on with confidence.
The opportunity here is straightforward. Apply intelligence where healthcare systems feel pressure every day and where the return on improvement is easy to recognize.
Governance Is Now Product Infrastructure
HIMSS 2026 also made something else very clear. Governance has moved from the margins of the conversation into the center of product evaluation.
Healthcare organizations are advancing with AI, though governance maturity remains uneven across the market. The gap between deployment speed and governance readiness came through clearly in the conference insights. Concerns around validation, monitoring, auditability, passive listening environments, and patient trust are growing. These concerns deserve serious attention because AI in healthcare operates inside sensitive, regulated, and deeply human settings.
Trust will shape adoption from here on.
As AI becomes part of everyday healthcare operations, organizations need to understand how outputs are grounded, how decisions are logged, how exceptions are handled, where human review fits, and what evidence is preserved throughout the workflow. These details directly influence whether a system feels deployable at scale.
Cybersecurity sits inside the same reality. HIMSS 2026 featured 49 dedicated cybersecurity sessions, and the focus on medical device security, access control, identity, and attack surface management reflected the urgency of the moment. Connected care environments are growing. Medical device fleets are growing. Remote monitoring programs are growing. Each of those shifts expands the importance of secure architecture and disciplined access governance.
This dramatically changes how healthcare technology has to be built.
Governance-first design, role-based access, evidence tracking, secure data movement, explainable outputs, and audit readiness are now part of the product story. They shape trust. They reduce uncertainty. They give enterprise buyers stronger reasons to move forward with confidence.
This is a critical path forward for Coditas. In healthcare, strong architecture is now inseparable from strong product thinking.
Revenue Cycle Remains the Clearest Proving Ground
Financial pressure continues to shape buying behavior across healthcare, and HIMSS 2026 reflected that reality clearly.
Healthcare organizations are still carrying the weight of reimbursement complexity, denials, administrative waste, staffing constraints, and the constant need to do more with limited capacity. That is one reason revenue cycle conversations continue to draw serious attention. They speak directly to cost, cash flow, visibility, and organizational control.
Hence, revenue-focused workflows remain such an important proving ground for healthcare AI.
Prior authorization, claims, denials, appeals, and documentation integrity are high-pressure environments with immediate business consequences. These workflows involve repetitive analysis, policy interpretation, evidence review, coordination across teams, and time-sensitive execution. They are exactly the kind of environments where intelligence can create visible operational return.
The market is looking for systems that support the full sequence of work with greater continuity. It wants stronger visibility into why denials occur, where cases are getting delayed, what information is missing, and how response quality can improve. Buyers are increasingly drawn to platforms that create connected workflow control rather than isolated workflow support.
For Coditas, this remains a strong strategic alignment. Revenue cycle intelligence matters because it addresses pain that buyers are already prioritizing. It also offers a clearer path to measurable value, which is exactly what this market wants right now.
Experience Quality Now Shapes Enterprise Healthcare Value
One of the most important lessons from HIMSS 2026 had everything to do with experience.
The popularity of the “Kill the Clipboard” message captured a real frustration inside healthcare. Patients are tired of repetition. Clinicians are tired of friction. Operational teams are tired of systems that create work instead of reducing it. The strongest demos at the event succeeded because they made the next step feel simpler, clearer, and easier to complete. Samsung and b.well’s QR-based record population stood out for that reason. The value was immediate. The interaction felt intuitive.
Consider it a strategic signal for the industry.
Experience quality now affects access, engagement, completion, communication, confidence, and trust. It influences whether a user can move through the workflow smoothly and whether the technology becomes part of everyday behavior. In healthcare, that applies to patients, clinicians, operators, device teams, and revenue cycle users alike.
The experience layer now carries strategic weight.
A system may be technically capable, though real value only shows up when the user can understand it, move through it, and trust what happens next.
That is an important part of the path forward for Coditas. Stronger alignment between engineering, AI, and experience design will decide how much value healthcare organizations actually capture from the systems they invest in.
The Way Ahead for Coditas
The deeper lesson from HIMSS 2026 is that healthcare is accelerating in a very specific direction.
The market is moving toward more active intelligence inside workflows. It is expecting stronger governance and security foundations. It is prioritizing measurable operational impact. It is demanding digital experiences that reduce friction across patients, clinicians, and enterprise users.
This gives us a very clear direction.
Coditas will continue to build where these forces intersect. Revenue cycle intelligence remains highly relevant because financial pressure still shapes technology priorities. Clinical and predictive intelligence matter in areas where trust, reproducibility, and actionability influence outcomes. Connected device ecosystems matter because distributed care and medical device operations continue to grow in scale and complexity. Experience-led healthcare products matter because usability still determines whether value is realized in the field.
We need to keep building systems that bring intelligence closer to action. We need to build regulated environments with secure and explainable foundations. We need to reduce fragmentation across healthcare workflows. We need to create digital experiences that support confidence, speed, and adoption.
Closing Thoughts
HIMSS 2026 gave the industry a clearer signal than most conferences do.
Healthcare technology is moving into a more exacting phase. Buyers want value they can defend. They want workflows that move faster with stronger control. They want systems that can be governed responsibly. They want digital experiences that feel usable under pressure. They want partners that understand how healthcare actually operates.
The acceleration continues, and it is creating a real opportunity for teams that build with focus and discipline.
